24-July-2026
Corporate News
 
Dr Reddy’s Q1FY27: Net Profit declines 69% YoY, impacted by Rs 239 crore semaglutide provisions
23-Jul-2026

Pharma major Dr Reddy’s Laboratories posted its Q1FY27 net profit at Rs 443.5 crore, declining 69% year-on-year from Rs 1,417.8 crore reported in Q1FY26. However, on a sequential basis, its consolidated net profit surged 97% from Rs 220.5 crore reported in the trailing quarter. The pharma company reported its consolidated revenue from operations at Rs 8,070.5 crore, down 5.5% from Rs 8,545.2 crore posted in the year-ago period. Sequentially, the revenue jumped 7.3% from Rs 7,516. 2 crore reported in Q4FY26.

News Source:- https://www.financialexpress.com/business/industry/dr-reddys-q1fy27-net-profit-declines-69-yoy-impacted-by-rs-239-crore-nbspsemaglutide-provisionsnbsp/4299449/